Cytokine-Based immunotherapy Part B

Cytokine-Based immunotherapy: Part B, Volume 401 delves into the intricate world of cytokines, the vital signaling proteins that orchestrate the immune response and their pivotal role in modulating various immune functions. From fundamental mechanisms to their therapeutic applications, this book offers a thorough examination of the latest trends and developments in leveraging cytokines for immunotherapy. Chapters cover Cytokine-based immunotherapy in pancreatic cancer, IL-33 and its pleiotropic role in cancer, Immunocytokines based on IL-12 for cancer therapy: enhancing efficacy and reducing toxicity, Cytokine network in immunosuppression and tumor development in glioblastoma, The Double-Edged Role of Interferon Gamma in Cancer Immunity, and much more.An additional section covers Engineering Interleukin-10 for Therapeutic Applications, IL-23 Blockade: A Strategy for Relieving Inflammatory Diseases. Targeting TNF-alpha examines the immunotherapeutic approach for alleviating neuropathic pain. The key role of immunomodulatory cytokines for the development of novel nk cell-based cancer therapies focuses on the importance of cytokines in developing new cancer treatments. Finally, complexities in the clinical development of TGFß inhibitors covers the challenges in creating inhibitors for TGFß. - Provides a comprehensive overview of cytokine-based immunotherapy, covering key concepts, mechanisms, and applications in the field of immunotherapy - Details the role of various cytokines in modulating immune responses, including their functions in immune activation, regulation, and response to pathogens - Explores the current and emerging therapeutic applications of cytokine-based immunotherapy in treating various diseases, such as cancer, autoimmune disorders, and infectious diseases